• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS NT-PROBNP II REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS NT-PROBNP II REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6192255
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/25/2023
Event Type  malfunction  
Manufacturer Narrative
The investigation has determined that lower than expected nt ¿ probnp ii (ntbnp ii) results were obtained when processing a non-vitros mas cardio-immune quality control (qc) fluid lot oim2503 on a vitros 5600 integrated system.The cause of the lower than expected vitros ntbnp ii qc sample results could not be determined.The qc review indicates there was within laboratory accuracy and precision issues with the customers level 1 qc fluid over the timeframe reviewed using vitros ntbnp ii lot 0160.There is no package insert (pi) data or peer data available for the vitros ntbnp ii to compare the customers qc results or the customers baseline data.It is not known how the customer obtains their baseline mean/sd data.No information was provided with regards to how the qc samples were handled prior to processing, therefore, it is possible that improper pre-analytical qc handling contributed to this event, however, this cannot be confirmed.The customer stated that the non-vitros mas qc fluids are stored refrigerated and are left to reach room temperature before use, however, no information was provided with regards to how long the vials had been reconstituted and how long the qcs were left to reach room temperature before processing, therefore, it is possible that improper pre-analytical qc handling contributed to this event, however, this cannot be confirmed.Within run vitros tsh precision testing carried out indicated acceptable instrument performance on 22 september 2023, however, no precision testing was carried out around the time of the events (25 august 2023, 17 september 2023 and 18 september 2023), therefore, an instrument issue cannot be entirely ruled out as a contributing factor.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros ntbnp ii reagent lot 0160.
 
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report lower than expected nt ¿ probnp ii (ntbnp ii) results were obtained when processing a non-vitros mas cardio-immune quality control (qc) fluid lot oim2503 on a vitros 5600 integrated system.Mas qc level 2 results of 307, 310.32, 312.70, 317.51 and 320.22 pg/ml vs expected result of 428 pg/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The lower than expected vitros ntbnp ii results were obtained when processing non-patient fluid.The customer made no indication that any patient sample results had been affected.There were no reported allegations of harm as a result of this event.This report is number one of two mdr¿s for this event.Two 3500a forms are being submitted for this event as two devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4) and reportability assessment (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS NT-PROBNP II REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS, INC.
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
microtyping systems
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key17916042
MDR Text Key326257188
Report Number3007111389-2023-00180
Device Sequence Number1
Product Code NBC
UDI-Device Identifier10758750002061
UDI-Public10758750002061
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/12/2023
Device Catalogue Number6192255
Device Lot Number0160
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/19/2023
Initial Date FDA Received10/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/14/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-